Recombinant GCDFP-15 Monoclonal Antibody (AN301529L)
Add to cart
For research use only.
| Verified Samples | Verified Samples in IHC: Human breast, Human breast cancer |
| Dilution | IHC 1:200-1:1000 |
| Isotype | IgG, κ |
| Host | Rabbit |
| Reactivity | Human, |
| Applications | IHC |
| Clonality | Monoclonal;Recombinant |
| Immunogen | Recombinant human GCDFP-15 fragment |
| Abbre | GCDFP-15 |
| Synonyms | GPIP, PIP, GCDFP-15, GCDFP15, GPIP4, BRST2, BRST-2, GCDGP15, gp17, Gross cystic disease fluid protein 15, Prolactin induced protein, Prolactin inducible protein precursor, Prolactin-induced protein, Prolactin-inducible protein, SABP, Secretory actin binding protein, Secretory actin-binding protein |
| Swissprot | |
| Cellular Localization | Cytoplasm |
| Concentration | 1 mg/mL |
| Buffer | PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant. |
| Purification Method | Protein A purified |
| Research Areas | Tags and Cell Markers, Cancer |
| Clone No. | A228 |
| Conjugation | Unconjugated |
| Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
| Shipping | Ice bag |
| background | Gross cystic disease fluid is a pathologic secretion from breast composed of several glycoproteins, including a unique 15,000-dalton monomer protein, GCDFP-15. Numerous histopathologic studies have shown GCDFP-15 (BRST-2) to be a specific marker for breast cancer in surgical specimens. |
| Cat.No. | Product Name | Clone No. |
|---|
-
IF：{{item.impact}}
Journal：{{item.journal}} ({{item.year}})
DOI：{{item.doi}}Reactivity：{{item.species}}
Sample Type：{{item.sample_type}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
